Home | All secondary_outcomes

[RDF data]
Secondary Outcomes #10046

Resource URI: http://static.linkedct.org/resource/secondary_outcomes/10046
rdfs:label Secondary Outcomes #10046
linkedct:measure Assess olanzapine compared with placebo in terms of suicidality or serious suicide risk, as determined by an investigator's clinical judgement or increase on the suicidality module of the Mini International Neuropsychiatric Interview.
linkedct:safety_issue Yes
is linkedct:secondary_outcomes of <http://static.linkedct.org/resource/trials/NCT00510146>
linkedct:secondary_outcomes_id 10046 (xsd:int)
linkedct:time_frame 10 weeks (includes screening period of 2-28 days)
rdf:type linkedct:secondary_outcomes